Recent years have seen automated technologies, such as machine learning and AI, really starting to take off. While these technologies are growing in popularity, we need to have realistic expectations. In an ideal world we could have voice-activated computers that can tell us in a brief second if a...
The global pharma industry has always been cautious when it comes to adopting new technologies. Returns on investment from research efforts are volatile and restrictive, everchanging regulations add to a culture that is already slow to adopt. Despite this, it would be difficult to find a time in the...
On October 24th, we welcomed our customers to our annual IDBS User Group Meeting: i3. This year, we chose a beautiful lakeside resort just outside of Austin, Texas, writes Christine Zubris, IDBS Customer Success Manager. While Austin experienced the worst flooding in a century (the lake at the venue...
Few technologies have leapt from science fiction to fact as quickly as artificial intelligence (AI). After years of build-up, and of promise and excitement, the high level of AI maturity, driven by high-performance computing power, is now ubiquitous. And, in the pharmaceutical industry, the potential for even more technological...
Usually organizations implement new IT strategies and adopt new technologies to keep ahead of the competition. But one charity is implementing a cloud-first strategy with a difference. The aim? To cease operations completely. Julie Dodd, Director of Digital Transformation and Communication at Parkinson’s UK, told ZDNet: “We want to...
In September, Christian Marcazzo joined us as Vice President and General Manager. Christian will be responsible for the day-to-day running of IDBS and growing the Informatics Solutions business of the Danaher Life Sciences Platform. Watch the interview below to hear Christian’s thoughts on everything from the future of drug...
Disaster recovery and backups are an often overlooked, but critical, component of managing an enterprise application. Both options are required to prevent catastrophic loss of data. Disaster recovery requires either off-site or multi-site storage – and organizations typically backup data every 24-hours. For events unrelated to catastrophic data loss,...
As the biologics market matures at an expected growth of 7-9% through to 2022 – reaching $3.8bn, it substantially influences the CMO/CDMO market with notable mergers and acquisitions in the space. This year we’ve seen Catalent’s acquisition of Juniper, Emergent BioSolutions’ acquisition of PaxVax and European-based cGMP, expanding its...
The biopharma space is constantly evolving thanks to the scientific community’s commitment to innovation to seek out new cures and ways to improve our health. These innovations, however, are often held back due to the often-outdated nature of commercial manufacturing. The Wall Street Journal once described pharmaceutical manufacturing processes...
Pharma and biotech companies have invested heavily in externalized research, development, and manufacturing in recent years – but their methods of sharing critical data are still rarely fit for purpose. Typically, collaborator data is simply packaged up in a PDF format and sent via email. Job well done, right?...
